Statins versus placebo for people with chronic obstructive pulmonary disease (COPD)

This review aims to evaluate available evidence on benefits and harms associated with statin therapy for patients with COPD. Primary objectives include the following.

  • To determine whether statins reduce mortality rates in COPD.
  • To determine whether statins reduce exacerbation frequency, improve quality of life or improve lung function in COPD.
  • To determine whether statins are associated with adverse effects.

This is a protocol.

Share/Save